Background & Aims: Chronic intake of proton pump inhibitors (PPI) has been associated with hypomagnesemia, but prevalence of PPI-associated hypomagnesemia is not known.

Methods: We examined the prevalence of hypomagnesemia among long-term PPI recipients by using a large health maintenance organization database. We collected data on 10,167 participants eligible for chronic drug prescriptions from 2008 through 2013. Adult subjects receiving continuous PPI therapy for ≥ 6 months between 2008 and 2013 and ≥ 1 serum magnesium determination(s) were identified. Patients with any magnesium levels less than 1.6 mg/dL were selected for analysis; those with recognizable causes of altered magnesium homeostasis were excluded.

Results: Five hundred ninety participants received long-term PPIs, and 414 (70.2%) met the inclusion criteria for a total exposure of 2293 PPI-years (average, 5.7 years/subject). Of these patients, 57 (13.8%) had ≥ 1 low serum magnesium; 5 were no longer on PPIs, and 44 had other recognizable causes for hypomagnesemia (25 receiving diuretics, 8 with chronic diarrhea, 8 with chronic kidney disease, and 3 with malignancies). Of the 8 remaining patients (7 female; mean age, 71.2 ± 13.4 years; mean daily medications, 5.4 ± 1.1), mild hypomagnesemia (range, 1.2-1.5 mg/dL) was noted in 13.9% of 289 measurements. All 8 patients had normal serum levels of magnesium at their final measurement.

Conclusions: In the absence of known precipitating factors, chronic PPI use does not appear to be associated with hypomagnesemia.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cgh.2015.10.012DOI Listing

Publication Analysis

Top Keywords

prevalence hypomagnesemia
8
hypomagnesemia long-term
8
proton pump
8
pump inhibitors
8
associated hypomagnesemia
8
2008 2013
8
serum magnesium
8
hypomagnesemia
7
chronic
5
magnesium
5

Similar Publications

Background: Acute kidney injury (AKI) is prevalent in patients hospitalized with ST-segment elevation myocardial infarction (STEMI) and is correlated with worse cardiovascular outcomes. Hypomagnesemia has been found to be associated with an elevated risk of AKI in various patient populations. Nonetheless, the relationship between hypomagnesemia and AKI incidence in patients with STEMI has not been fully elucidated.

View Article and Find Full Text PDF

Purpose: It has been assumed that magnesium (Mg) status may interact with vitamin D status. We therefore aimed at investigating the association between Mg and vitamin D status in a large cohort of adult individuals with a high prevalence of deficient/insufficient vitamin D and Mg status.

Methods: We used data from the Ludwigshafen Risk and Cardiovascular Health Study (n = 2,286) to analyze differences according to serum Mg status in circulating 25-hydroxyvitamin D [25(OH)D] (primary endpoint), 24,25-dihydroxyvitamin D [24,25(OH)D], vitamin D metabolite ratio and calcitriol, and odds ratios for deficient or insufficient 25(OH)D (secondary endpoints).

View Article and Find Full Text PDF

Patients with primary hyperparathyroidism (PHPT) are predisposed to hypomagnesemia as well as hypophosphatemia. In the current literature, scarce data was available on the clinical significance of hypomagnesemia in PHPT. The present study aimed to investigate the prevalence of hypomagnesemia and its association with complications of PHPT in a large nationwide cohort.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the link between magnesium (Mg) levels and depression in patients on peritoneal dialysis (PD) at Handan First Hospital, China, noting that those with low Mg levels show a higher prevalence of depressive symptoms.
  • Using a cohort of 140 patients, the researchers employed the Hamilton Depression Scale to assess mental health and conducted various analyses to find predictors of depression.
  • Results indicated a significant correlation between low serum Mg levels, hemoglobin concentration, unemployment, and the likelihood of depression, suggesting that improving Mg levels could help prevent depression in these patients.
View Article and Find Full Text PDF

Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex).

Sci Rep

November 2024

Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 8128582, Japan.

Article Synopsis
  • - Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a systemic issue that negatively impacts the health and prognosis of CKD patients, making effective management crucial.
  • - This study analyzed data from 30,977 CKD patients in the Japan Chronic Kidney Disease Database Extension to explore the link between proteinuria and CKD-MBD.
  • - Results indicated that higher levels of proteinuria (up to 3+) are significantly associated with increased risks of hyperphosphatemia, hypocalcemia, and hypomagnesemia, regardless of kidney function measured by eGFR.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!